IgM multiple myeloma: Report of four cases and review of the literature

Leukemia and Lymphoma

Volumn 47, Issue 8, 2006, Pages 1565-1569

  Annibali, Ombretta ^a   Petrucci, Maria Teresa ^b   Del Bianco, Patrizia ^b   Gallucci, Cristiano ^b   Levi, Anna ^b   Foà, Robin ^b   Avvisati, Giuseppe ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

IgM gammopathy; IgM myeloma; Macroglobulinemia; Myeloma; Waldenstr m's macroglobulinemia

Indexed keywords

ALPHA INTERFERON; CALCIUM; CARBOPLATIN; CREATININE; GEMCITABINE; HEMOGLOBIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; MELPHALAN; NITROGEN; PACLITAXEL; PREDNISONE; UREA;

ADULT; AGED; ANEMIA; ARTICLE; ASTHENIA; BACKACHE; BONE MARROW BIOPSY; CANCER STAGING; CANCER SURVIVAL; CANDIDIASIS; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DISEASE SEVERITY; ELECTROPHORESIS; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY FAILURE; LAMINECTOMY; LIVER DISEASE; LUNG SQUAMOUS CELL CARCINOMA; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PLASMA CELL; PRIORITY JOURNAL; RESPIRATORY FAILURE; SPINAL CORD COMPRESSION; STROKE; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TREATMENT REFUSAL; UREA NITROGEN BLOOD LEVEL; URINARY TRACT INFECTION; VERTEBRA FRACTURE; WEIGHT REDUCTION;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MULTIPLE MYELOMA; WALDENSTROM MACROGLOBULINEMIA;

EID: 33748549958     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600604450     Document Type: Article

References (26)

1. Kyle, R. (1992) Diagnostic criteria of multiple myeloma Hematol Oncol Clin N Am, 6, pp. 347-358.
2. De Gramont, A and Grosbois, B and Michaux, J and Peny, A and Pollet, J and Smadja, N and (1990) IgM myeloma: 6 cases and a review of literature La Revue de Medicine Interne, 11, pp. 13-18.
3. Grogan, T and Spier, C.(1992) The B cell immunoproliferative disorders, including multiple myeloma and amyloidosis. In Neoplastic hematopathology. (pp. 1235-1265). Baltimore: Williams and Wilkins.
4. Dimopoulos, M and Panayiotidis, P and Moulopoulos, L and Sfikakis, P and Dalakas, M. (2000) Waldenström's macroglobulinemia: Clinical features, complications and management J Clin Oncol, 18, pp. 214-226.
5. Zarrabi, M and Stark, R and Kane, P and Dannaher, Cl and Chandors, S. (1981) IgM Myeloma, a distinct entity in the spectrum of B cell neoplasia Am J Clin Pathol, 75, pp. 1-10.
6. Bachman, R. (1965) The diagnostic significance of the serum concentration of pathological proteins (M-components) Acta Med Scand, 178, pp. 801-808.
7. MacLennan, I. (1992) In which cells does neoplastic transformation occur in myelomatosis? Curr Topics Microbiol Immunol, 182, pp. 209-213.
8. Kyle, R. (1987) The spectrum of IgM monoclonal gammopathy in 430 cases Mayo Clin Proc, 62, pp. 719-731.
9. Takahashi, K and Yamamura, F and Motoyama, H. (1986) IgM myeloma: Its distinction from Waldenström's macroglobulinemia Acta Pathol Jap, 36, pp. 1553-1563.
10. Haghighi, B and Yanagihara, R and Cornbleet, J. (1998) IgM myeloma: Case report with immunophenotypic profile Am J Hematol, 59, pp. 302-308.
11. Ho, C and Chen, Y and Yiang, Y and Kao, W. (1999) Mandibular mass as the presenting manifestation of IgM myeloma in a 22-years old man Ann Hematol, 78, pp. 93-95.
12. Kondo, H and Yokoyama, K. (1999) IgM myeloma: Different features from multiple myeloma and macroglobulinaemia Eur J Haematol, 63, pp. 366-368.
13. Dierlamm, T and Laack, E and Dierlamm, J and Fiedler, W and Hossfeld, D. (2002) IgM myeloma: A report of four cases Ann Hematol, 81, pp. 136-139.
14. Chenal, A and Taher, A and Shamseddine, A. (2003) IgM myeloma and Waldenström's macroglobulinemia: A distinct clinical feature histology, immunophenotype, and chromosomal abnormality Clin Lab Haematol, 25, pp. 187-190.
15. Stellmacher, F and Sotlar, K and Balleisen, L and Valent, P and Horny, H. (2004) Bone marrow mastocytosis associated with IgM kappa plasmacell myeloma Leuk Lymphoma, 45, pp. 801-805.
16. Durie, B and Salmon, S. (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival Cancer, 36, pp. 842-854.
17. Kyle, R and Therneau, T and Rajkumar, S and Remstein, E and Offord, J and Larson, D and (2003) Long term follow-up of IgM monoclonal gammopathy of undetermined significance Blood, 102, pp. 3759-3764.
18. The International Myeloma Working Group. (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group Br J Haematol, 121, pp. 749-757.
19. Berman, H. (1974) Waldenström's macroglobulinemia with lytic osseous lesions and plasma-cell morphology: Report of a case Am J Clin Pathol, 63, pp. 397-402.
20. Weick, J and Crowley, J and Hussein, M and Moore, D and Barlogie, B. (2002) The evaluation of gemcitabine in resistant or relapsing multiple myeloma phase II: A Southwest Oncology Group study Invest New Drugs, 20, pp. 117-121.
21. Offidani, M and Miele, A and Corvatta, L and Marconi, M and Malerba, L and Olivieri, A and (2002) Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple myeloma Leuk Lymphoma, 43, pp. 1273-1279.
22. Leleu, X and Troncy, J and Bouafia, F and Michallet, M and Facon, T and Dumontet, C. (2004) Evaluation of gemcitabine in relapsed or refractory multiple myeloma Haematologica, 89, pp. ELT15.
23. Avet-Louseau, H and Garand, R and Lode, L and Harousseau, J and Bataille, R. (2003) Intergroupe Francophone du Myelome. Translocation t(11;14)(q13; q32) is the hallmark of IgM, IgE and nonsecretory multiple myeloma variants Blood, 101, pp. 1570-1571.
24. Annibali, O and Petrucci, M and Martini, V and Tirindelli, M and Levi, A and Fossati, C and (2005) Treatment of 72 newly diagnosed Waldenström's macroglobulinemia patients with oral Melphalan, Cyclophosfamide and Prednisone (MCP): Results and cost analysis Cancer, 103, pp. 582-587.
25. Dimopoulos, M and Merlini, G and Leblond, V and Anagnostopoulos, A and Alexanian, R. (2005) How we treat Waldenström's macroglobulinemia Haematologica, 90, pp. 117-125.
26. Lin, P and Owen, R and Tricot, G and Wilson, C. (2004) Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma Am J Clin Patholol, 121, pp. 482-488.